Circulating miRNA-19b as a biomarker of disease progression and treatment response to baricitinib in rheumatoid arthritis patients through miRNA profiling of monocytes.

Front Immunol · 2023 · PMC10086423 · PMID 37056771

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The rest miRNA (-29c-5p, -374a-5p, -589-5p, -3614-5p) did not reach statistical significance before and after baricitinib treatment ( Figure 5B, C, E, F ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.